A new publication involving corticorelin, also known as corticotropin-releasing factor, appeared on November 1, 2026. The article, titled "Corticotropin-Releasing Factor: A Key Player in Intestinal Barrier Dysfunction of Diarrhea-Predominant Irritable Bowel Syndrome-A Narrative Mechanistic Review," was published in the journal Drug Design, Development and Therapy.
The work is described as a narrative mechanistic review. It is indexed under PubMed ID 42992095. No specific findings, conclusions, or data from the review have been disclosed here beyond its title and publication details.
Corticorelin is an approved compound. This publication represents a scientific literature entry rather than a clinical trial result or regulatory action. Readers interested in the broader context of corticorelin, including its approved uses and general background, can consult the compound overview for further information.